Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Current Diabetes Reports|July 31, 2012
Autologous regulatory T cells for the treatment of type 1 diabetesJames A Thompson, Daniel Perry, Todd M BruskoImmunological Reviews|July 11, 2008
Human regulatory T cells: role in autoimmune disease and therapeutic opportunitiesTodd M Brusko, Amy L Putnam, Jeffrey A BluestoneScience (New York, N.Y.)|July 30, 2021
Strategies for durable β cell replacement in type 1 diabetesTodd M Brusko, Holger A Russ, Cherie L StablerCurrent Opinion in Endocrinology, Diabetes, and Obesity|May 31, 2019
Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetesMelanie R Shapiro, Mark A Atkinson, Todd M BruskoFrontiers in Endocrinology|November 3, 2017
Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 DiabetesMark A Wallet, Katherine E Santostefano, Naohiro Terada, et al.Immunotherapy|November 29, 2013
Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetesAltin Gjymishka, Roxana M Coman, Todd M Brusko, et al.Diabetes|December 22, 2011
Central role for interleukin-2 in type 1 diabetesMaigan A Hulme, Clive H Wasserfall, Mark A Atkinson, et al.International Journal of Molecular Sciences|August 8, 2018
Myeloid-Derived Suppressor Cells and Pulmonary HypertensionAndrew J Bryant, Borna Mehrad, Todd M Brusko, et al.Current Diabetes Reports|October 13, 2017
T Cell Receptor Profiling in Type 1 DiabetesLaura M Jacobsen, Amanda Posgai, Howard R Seay, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cellsTodd M Brusko, Clive H Wasserfall, Anupam Agarwal, et al.Pageof 14